Chainalysis has bought Excygent, a cybercrime investigation company
Together, they will study the use of cryptocurrencies in hacker attacks
07.10.2021 - 08:10
1320
1 min
0
What's new? Chainalysis, an analytical blockchain company, has acquired Excygent, a cybercrime investigation company, according to its press release. The amount of the transaction is not disclosed.
Why did Chainalysis buy Excygent? Chainalysis CEO Michael Gronager stated that Excygent’ employees will join the Chainalysis team to investigate the use of cryptocurrencies in cybercrimes. Previously, the parties had already cooperated in the course of studying the anonymous online darknet market Silk Road.
What else is known about Chainalysis? In 2020, the company participated in a cybercrime investigation of the NetWalker ransomware that had attacked software in US hospitals. At that time the hospitals paid $25 million in ransom.
The project has grown significantly over the past year, receiving support from both the US government and the private sector. In June, the company reached a valuation of $4,2 billion after another $100 million round of funding. It was led by the global investment company Coatue.
Useful material?
Incidents
Developers warned of potential risks to bridges across the ecosystem and asked exchanges for assistance.
Jun 22, 2026
Incidents
The defendant helped move funds stolen through investment scams and earned at least $4 million for his role in the operation.
Jun 10, 2026
Incidents
The company is linking the incident to a compromised private key on a service wallet, rather than a smart contract exploit
May 22, 2026
Incidents
Following the incident, the project temporarily halted trading operations and node activity.
May 15, 2026
Incidents
The user spent weeks unsuccessfully trying to guess the password until Claude helped find an old wallet backup file
May 14, 2026
Crypto regulations
Authorities are introducing mandatory registration for companies handling cross-border crypto transactions
May 8, 2026
Telegram
Twitter